Specifically, NKX2-8 interacts with HDAC1 to form a complex that suppresses PTHrP transcription in breast cancer cells with no bone metastasis, while silencing NKX2-8 could eliminate its inhibition of bone metastasis. Here, NKX2-8 is linked to breast cancer.